Osteoarthritis pathophysiology
| https://https://www.youtube.com/watch?v=sUOlmI-naFs%7C350}} |
|
Osteoarthritis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Osteoarthritis pathophysiology On the Web |
|
American Roentgen Ray Society Images of Osteoarthritis pathophysiology |
|
Risk calculators and risk factors for Osteoarthritis pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Pathophysiology
Osteoarthritis (OA) is a well-known degenerative joint disease influencing millions of peopleworldwide. Osteoarthritis count as a complex disease caused by changes in the tissue homeostasis of articular cartilages and subchondral bones. The cell/extra-cellular matrix (ECM) and their interactions play an important role in the pathophysiology of articular cartilage and the occurrence of Osteoarthritis; consequently, the main feature of OA is that after this process in involved joint the articular cartilages of involved joint no longer have a normal acting system and for example because of the the extracellular matrix destruction this articular cartilages cannot act as a shock absorber. Different pathogenic mechanisms have been proposed to be responsible for the occurrence of OA. Heredity, obesity, hypoxia, synovitis–capsulitissubchondral bone overload, joint instability (mechanical integrity disturbances) are the most important underlying causes in this regard. In the current pathogenesis of osteoarthritis (OA) all joint tissues including cartilage, bone, synovium, ligamentous capsular structures, and surrounding muscle are involved. OA characterized by structural changes such as: active bone remodeling, synovial inflammation, and articular cartilage degradation leading to the loss of joint function and angular deformity or malalignment. Also, a variety of bio markers in synovial fluid helped to create more clear insight about the biological response of joints to injury but no biomarker have been declared to be reliable for monitoring the development, progression, and response to therapy of OA. Its been reported that certain factors can increase the risk of the OA development such as: hereditary elements, trauma and mechanical stress, joint injury, age, obesity, physical activity, bone mineral density (BMD), congenital anomalies. and, during the last years signaling pathways mad a lot of attention and its been proven that these pathways play important rolls in inflammation in the remodeling subchondral bone, synovium, enzyme activation, and extracellular matrix degradation in articular cartilage.